Aclarion, Inc. ACON

Company Overview

Aclarion, Inc. is a U.S.-based healthcare technology company focused on advancing diagnostic support tools for chronic low back pain and degenerative spine conditions. The company operates in the medical technology and digital healthcare sectors, with a primary emphasis on leveraging magnetic resonance spectroscopy (MRS), proprietary software analytics, and artificial intelligence-driven data interpretation to assist physicians in identifying painful intervertebral discs. Its core commercial platform is Nociscan, a software-as-a-service diagnostic support technology designed to analyze MR spectroscopy data and help clinicians evaluate disc chemistry associated with chronic low back pain.

The company’s principal customers include spine surgeons, radiologists, integrated health systems, and outpatient imaging centers involved in musculoskeletal and spinal care. Aclarion’s positioning is based on its effort to provide objective, noninvasive diagnostic insights in an area where treatment decisions have historically relied heavily on subjective clinical interpretation and conventional imaging. The company traces its origins to technology and intellectual property developed around quantitative spinal imaging analytics and became publicly traded through a merger transaction involving a special purpose acquisition company in 2022. Public filings and company disclosures indicate that commercialization efforts have focused on expanding physician adoption, payer engagement, and strategic imaging partnerships.